Formaldehyde dehydrogenase

Ubiquitous function

This enzyme can catalyse the conversion of many alternative substrates, including alcohols such as retinol, which it converts to retinal. It also has an important role in the metabolism of nitric oxide, which is reactive and often found in tissue in the form of S-nitrosoglutathione (GSNO), its adduct with glutathione (GSH). The enzyme is a class III alcohol dehydrogenase (ADH) encoded by the ADH5 gene in humans and can act as a S-nitrosoglutathione reductase (GSNOR). It is a primordial ADH that is ubiquitously expressed in plant and animals alike. GSNOR reduces GSNO to the unstable intermediate, S-hydroxylaminoglutathione, which then rearranges to form glutathione sulfinamide, or in the presence of excess GSH, forms glutathione disulfide and hydroxylamine.

Through this catabolic process, GSNOR regulates the cellular concentrations of GSNO and plays a central role in regulating the levels of endogenous S-nitrosothiols and controlling protein S-nitrosylation-based signaling. As an example of S-nitrosylation-based signaling, Barglow et al. showed that GSNO selectively S-nitrosylates reduced thioredoxin at cysteine 62. Nitrosylated thioredoxin, via directed protein-protein interaction, trans-nitrosylates the active site cysteine of caspase-3 thus inactivating caspase-3 and preventing induction of apoptosis.

As might be expected of an enzyme involved in regulating NO levels and signaling, pleiotropic effects are observed in GSNOR knockout models. Deleting the GSNOR gene from both yeast and mice increased the cellular levels of GSNO and nitrosylated proteins, and the yeast cells showed increased susceptibility to nitrosative stress. Null mice show increased levels of S-nitrosated proteins, increased beta adrenergic receptor numbers in lung and heart, diminished tachyphylaxis to β2-adrenergic receptor agonists, hyporesponsiveness to methacholine and allergen challenge and reduced infarct size after occlusion of the coronary artery. In addition, null mice show increased tissue damage and mortality following challenge with bacteria or endotoxin and are hypotensive under anesthesia yet normotensive in the conscious state. More related to its alcohol dehydrogenase activity, GSNOR null mice show a 30% reduction in the for formaldehyde and a decreased capacity to metabolize retinol, although it is clear from these studies that other pathways exist for the metabolism of these compounds.

Role in disease

It has been shown that GSNOR may have an important role in respiratory diseases such as asthma. GSNOR expression has been inversely correlated with S-nitrosothiol (SNO) levels in the alveolar lining fluid in the lung and with responsiveness to methacholine challenge in patients with mild asthma compared to normal subjects. Furthermore, there are lowered SNOs in tracheal irrigations in asthmatic children with respiratory failure in comparison to normal children undergoing elective surgery and NO species are elevated in asthma patients when exposed to antigen.

Assessing the gene expression of the ADHs in nonalcoholic steatohepatitis (NASH) patients has shown elevated levels of all ADHs, but primarily ADH1 and ADH4 (up to 40-fold increased). ADH5 showed a ~4-fold increase in gene expression.

Structural studies

As of late 2007, only one structure has been solved for this class of enzymes, with the PDB accession code .

References

References

1. {{KEGG enzyme. 1.2.1.46
2. (1980). "Enzymological aspects of caffeine demethylation and formaldehyde oxidation by Pseudomonas putida C1". Hoppe-Seyler's Z. Physiol. Chem..
3. (2017). "The role of S-nitrosoglutathione reductase (GSNOR) in human disease and therapy". Critical Reviews in Biochemistry and Molecular Biology.
4. (April 1998). "S-Nitrosoglutathione is a substrate for rat alcohol dehydrogenase class III isoenzyme". Biochem. J..
5. (March 2003). "Reduction of S-nitrosoglutathione by human alcohol dehydrogenase 3 is an irreversible reaction as analysed by electrospray mass spectrometry". Eur. J. Biochem..
6. (March 2009). "The Janus face of alcohol dehydrogenase 3". Chem. Biol. Interact..
7. (August 2011). "Site-specific and redox-controlled S-nitrosation of thioredoxin". Proc. Natl. Acad. Sci. U.S.A..
8. (August 2005). "Thioredoxin catalyzes the S-nitrosation of the caspase-3 active site cysteine". Nat. Chem. Biol..
9. (March 2001). "A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans". Nature.
10. (May 2007). "Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2". Cell.
11. (June 2005). "Protection from experimental asthma by an endogenous bronchodilator". Science.
12. (April 2009). "Endogenous S-nitrosothiols protect against myocardial injury". Proc. Natl. Acad. Sci. U.S.A..
13. (February 2004). "Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock". Cell.
14. (April 2002). "Stimulation of retinoic acid production and growth by ubiquitously expressed alcohol dehydrogenase Adh3". Proc. Natl. Acad. Sci. U.S.A..
15. (June 1999). "Metabolic deficiencies in alcohol dehydrogenase Adh1, Adh3, and Adh4 null mutant mice. Overlapping roles of Adh1 and Adh4 in ethanol clearance and metabolism of retinol to retinoic acid". J. Biol. Chem..
16. (August 2009). "S-nitrosoglutathione reductase: an important regulator in human asthma". Am. J. Respir. Crit. Care Med..
17. Dweik RA. (June 2001). "The promise and reality of nitric oxide in the diagnosis and treatment of lung disease". Cleve Clin J Med.
18. (2010). "Role of alcohol metabolism in non-alcoholic steatohepatitis". PLOS ONE.